Weight-loss drugs may lower risk of stroke and dementia, study finds

New research suggests that weight-loss drugs like Ozempic and Wegovy may lower the risk of conditions such as stroke and dementia. The study analyzed data from diabetes patients using GLP-1 receptor agonists, showing improved heart health and reduced risks of various disorders. The findings indicate a decreased likelihood of developing Alzheimer’s and Parkinson’s among users of these drugs compared to those on standard treatments. However, experts caution that more research is needed to confirm these benefits and highlight potential risks, including gastrointestinal issues. While the study provides reassurance about the long-term safety of GLP-1 receptor agonists, it is observational and not definitive. Ongoing randomized trials are expected to provide clearer insights into the effects of these drugs on obesity and related health outcomes.